Background: Neurally adjusted ventilatory assist (NAVA) delivers assist in proportion to the patient's respiratory drive as reflected by the diaphragm electrical activity (EAdi). We examined to what extent NAVA can unload inspiratory muscles, and whether unloading is sustainable when implementing a NAVA level identified as adequate (NAVAal) during a titration procedure. Methods: Fifteen adult, critically ill patients with a PaO 2 /fraction of inspired oxygen (FIO 2 ) ratio < 300 mm Hg were studied. NAVAal was identified based on the change from a steep increase to a less steep increase in airway pressure (Paw) and tidal volume (VT) in response to systematically increasing the NAVA level from low (NAVAlow) to high (NAVAhigh). NAVAal was implemented for 3 h. 
I
n critically ill patients, the application of mechanical ventilation should ensure sufficient ventilation, avoid excessive exertion or disuse of the respiratory muscles, and avoid ventilator-induced lung injury. Given the high variability in disease processes and states, the application of predefined, uniform values for ventilator parameters, such as tidal volume (Vt) or airway pressure (Paw), is unlikely to provide optimal assist at all times. How to tailor ventilator settings to each individual patient is difficult due to the lack of tools for monitoring patients' respiratory demand and responses to mechanical ventilation.
Neurally adjusted ventilatory assist (NAVA) delivers pressure in proportion to the electrical activity of the diaphragm (EAdi) throughout inspiration 1 and hence responds to the patient's respiratory drive. A proportionality factor (referred to as the NAVA level) determines the delivered pressure for a given EAdi amplitude (ie, centimeters of H 2 O per unit of EAdi). Studies in animals and healthy volunteers have demonstrated that NAVA protects against excessive Paw and Vt by a down-regulation of EAdi at high NAVA levels, 2, 3 unloads the respiratory muscles, and improves subject-ventilator synchrony. 4 The aim of the present study was to evaluate to what extent NAVA can unload inspiratory muscles, and whether unloading without evidence of progressing respiratory failure is sustainable when implementing a NAVA level identified as adequate (NAVAal) during a titration procedure. We hypothesized that the down-regulation of EAdi in response to the stepwise increase in the NAVA level prevents excessive increases in Paw and Vt once the level of assist satisfies the patient's respiratory demand. We assumed that such a patient-controlled limitation of Paw and Vt during a NAVA level titration procedure can be used to identify a NAVA level that results in stable cardiopulmonary function when implemented for 3 consecutive h. Invasively ventilated patients (PaO 2 /fraction of inspired oxygen [Fio 2 ] ratio Յ 300 at Fio 2 Յ 0.8) who were stable from a cardiopulmonary perspective and who were able to pneumatically trigger the ventilator were eligible for the study, regardless of the assist level used during conventional ventilation (CoVent). Settings for CoVent and positive end-expiratory pressure (PEEP) level were used as prescribed by the clinician. Exclusion criteria and detailed methods are provided in the online supplementary material.
Materials and Methods

Patients
NAVA Methods
All patients were ventilated with a commercially available ventilator (Servo300 ventilator; Maquet; Solna, Sweden) modified to perform both CoVent and NAVA. During NAVA the ventilator was controlled by the EAdi that was processed as previously described by Sinderby and colleagues. 1, [5] [6] [7] [8] Briefly, during NAVA the EAdi signal is used to trigger cycle-on and cycle-off the inspiratory assist. The delivered Paw during inspiration is determined by the EAdi amplitude multiplied by a proportionality factor (NAVA level) every 16 ms.
Study Protocol
NAVA Level Titration: Schematic figures of the study protocol are provided in the online supplement (Figs E1 and E2). First, in order to increase respiratory drive while not provoking too much distress, the NAVA level was reduced to a minimal level of 0.1 to 1.0 cm H 2 O/arbitrary units (au), resulting in a minimal assist of 3.2 cm H 2 O (quartiles, 2.0 to 4.0 cm H 2 O) above PEEP for a total of 3 min or until the EAdi doubled. This lowest NAVA level will subsequently be referred to as NAVAlow.
When sufficient EAdi was detectable, as defined by a maximum EAdi signal during NAVAlow of about two times the trigger level, a NAVA level titration was performed as follows: the NAVA level was increased every third minute in steps of 1 cm H 2 O/au while observing the Paw response displayed in a trend graph. The transition from an initial steep increase in Paw (first response) to a less steep increase in Paw (second response) was identified by visual inspection of the Paw trend graph (Fig E2 in the online  supplementary material) . The NAVA level at the transition from the first to the second response was identified as the NAVAal. Follow-up: The EAdi was recorded daily for 10 min for up to 7 days during CoVent.
Measurements
EAdi was measured with an array of electrodes mounted on a nasogastric tube that also contained a balloon to measure esophageal pressure (Pes). 9 Flow was obtained from the ventilator, and Paw was measured at the Y-piece. The signals for EAdi, flow, Paw, and Pes were monitored continuously online and recorded intermittently. Arterial BP and blood gas levels were obtained from a radial artery line. Echocardiography was performed (Sonos 5500; Philips Ultrasound; Bothell, WA) during CoVent and during the third hour receiving NAVAal.
Data Analysis
Mean inspiratory deflections of EAdi, Pes, and Paw, neural inspiratory time (Tineural), and ventilator inspiratory time were analyzed off-line breath-by-breath. Vt was derived by integrating inspiratory flow. Dynamic lung compliance (CLdyn), mean dynamic transpulmonary pressure (Ptp) during inspiration, esophageal pressure time product (PTPes), ventilator pressure time product, neural respiratory rate (RRneural), ventilator respiratory rate (RRvent), minute ventilation (V e), and coefficients of variation were calculated. Average values of all breaths during 5-min periods are reported.
Statistical Analysis
The data were not normally distributed (Kolmogorov-Smirnov test). Statistical analysis was performed using a statistical software package (SigmaStat, version 3.11; Systat Software Inc; San Jose, CA). The Wilcoxon signed rank test was used to compare groups with paired data. The Friedman test was used for repeated measurements. Correlation was assessed by linear regression. The level of significance was p Ͻ 0.05.
Results
Results are presented as the median (quartiles). A convenience sample of 15 patients was enrolled into the study. For patient characteristics, see Table 1 . In 14 patients, the maximum EAdi reached between 2.1 and 5.5 times the trigger level during NAVAlow, and between 1.9 and 4.0 times the trigger level during the application of NAVAal. In patient 11, the maximum EAdi at NAVAlow was below the trigger level, and this patient was excluded from the NAVA portion of the study.
NAVA Level Titration
Changes observed for Vt, Paw, EAdi, and PTPes during titration of the NAVA level are shown in Figure  1 (and Fig E2 in the online supplementary material) for a single patient and in Figure 2 for the group. The relationship among Paw, Pes, and Ptp during the NAVA level titration is depicted in Figure 3 . During the first response, Paw and Ptp increased while Pes remained unchanged; whereas, during the second response the relationship between Paw and Pes paralleled the Ptp isopleths such that the lung-distending pressure (and hence Vt) remained unchanged despite a continued increase in the NAVA level.
PEEP Reduction Trial
The measured PEEP at the prescribed level was 8.5 cm H 2 O (quartiles, 5.3 to 11.8 cm H 2 O) and was reduced to 2.8 cm H 2 O (quartiles, 2.4 to 3.5 cm H 2 O; p Ͻ 0.001) over 11 min (quartiles, 8 to 13 min) causing the mean expiratory EAdi and RRneural to increase by 3% (quartiles, 1 to 6%; p ϭ 0.005) and by 2.2 breaths/min (quartiles, 0.3 to 3.1 breaths/min; Figure 1 . A: changes in Vt per PBW, mean inspiratory Paw including PEEP, EAdi, and PTPes in a single patient while increasing the NAVA level at a constant rate (ie, one level every third minute) from NAVAlow to NAVAhigh. Initially, the increase in Paw and Vt was associated with a progressive reduction in EAdi and PTPes (first response). At some NAVA level, the increases in Paw slowed down, and Vt (and Ptp, not shown) reached a plateau despite a continued increase of the NAVA level at a fixed rate due to further down-regulation of EAdi (second response). Thereafter, the EAdi did not decrease any further, and consequently Paw and Vt resumed their increases in response to increases in the NAVA level. The NAVA level at the transition from the first to the second response was identified as an adequate NAVA level (NAVAal) and was subsequently applied for 3 h (see also Figure E2 in the online supplementary material). EAdi and PTPes are expressed as a percentage of their values at NAVAlow (%NAVAlow). Facing page, B: examples of tracings obtained in the same patient during CoVent, at NAVAlow, NAVAal, and NAVAhigh. Note that assist was delivered in synchrony and proportionality to the EAdi even when the breathing pattern became irregular at NAVAhigh. A similar irregular breathing pattern was observed during CoVent that, in contrast to NAVA, delivers uniform assist for each breath. p Ͻ 0.05), respectively. No changes were observed for mean inspiratory EAdi, Vt, and pulse oximetric saturation.
Implementation of NAVAal for 3 h
Throughout the 3 h receiving NAVAal, there were no significant changes over time in Vt, Paw, EAdi, Pes, PTPes, Tineural, RRneural, V e, PAco 2 , PAo 2 / Fio 2 ratio (Fio 2 remained unchanged during the study in all patients), arterial pH, mean arterial pressure, heart rate, and sedation agitation scale (SAS) score (see Table E1 in the online supplementary material). The average values for Vt, Paw, EAdi, and PTPes during 3 h receiving NAVAal were not different from the values observed at NAVAal during the NAVA level titration (Fig 2) .
Comparison of NAVAal at the end of the 3 h of ventilation to CoVent (Table E2) showed slight increases for V e and RRneural (p Ͻ 0.05 for both); large decreases for Paw, Ptp, ventilator pressure time product, and ventilator inspiratory time (p Ͻ 0.05 for all); and minute decreases for Vt and Tineural (p Ͻ 0.05). The coefficient of variation for Vt during CoVent was 9.1% (quartiles, 6.5 to 12.5%) and was increased to ; p ϭ 0.041), while cardiac index, left ventricular ejection fraction, and all other parameters assessed by echocardiography remained unchanged when compared to CoVent (difference not significant for all comparisons). The average Vt during 3 h receiving NAVAal was significantly correlated (r ϭ 0.62; p ϭ 0.017) with CLdyn (Fig 4) .
The nasogastric NAVA catheter remained in situ for 5 days (quartiles, 3 to 7 days). During the follow-up period, the average of the maximum EAdi amplitude was 3.2 times the trigger level (quartiles, 2.7 to 3.7 times the trigger level). In the patient who could not be ventilated with NAVA, the maximum EAdi amplitude during follow-up exceeded two times the trigger level on follow-up day 3. 
Discussion
The present study demonstrates that systematically increasing the NAVA level in critically ill patients results in 74% unloading of the inspiratory muscles. NAVAal was identifiable based on the transition from an increase in the lung-distending pressure at lower NAVA levels to a limitation of the lung-distending pressure at higher NAVA levels.
Partial unloading of the inspiratory muscles during implementation of NAVAal for 3 h (PTPes was reduced by 55%NAVAlow and EAdi was reduced by 24%NA-VAlow) seemed to satisfy the respiratory demand of the patients as evidenced by stable respiratory parameters and cardiopulmonary function.
In agreement with previous work in rabbits with acute lung injury, 4 ,10 the present study demonstrated a two-phased response to increasing the NAVA level (Figs 1-3; Fig E2 in the online supplementary  material) . At lower NAVA levels, Paw, Vt, and Ptp increased (first response) while inspiratory muscles were progressively unloaded (ie, EAdi and PTPes decreased). At higher NAVA levels, the rate of increase in Paw slowed down and Vt as well as Ptp plateaued (second response) while unloading of the inspiratory muscles continued (EAdi and PTPes further decreased).
During the first response, the Paw and Pes relationship crossed the Ptp isopleths (ie, the lungdistending pressure, and hence the Vt, increased while the inspiratory effort was only minutely de- creased) [Fig 3] . During the second response, the Paw and Pes relationship paralleled the Ptp isopleths (ie, the lung-distending pressure, and hence the Vt, remained unchanged while the inspiratory efforts were substantially decreased). Different from the results of the present work, we demonstrated that Vt and Ptp did not change when performing a similar NAVA level titration in healthy volunteers, suggesting that in the absence of respiratory failure (ie, when the subject's respiratory demand is satisfied even without ventilatory assist) the predominant response to increasing NAVA level is the prevention of further lung distension (ie, the second response). 3 Marantz et al 11 varied the level of assist with proportional assist ventilation (PAV) from nearmaximal levels to the lowest tolerable level and found that unique values for V e, Vt, and RR were identifiable for each patient. Similar to the present study, increasing the PAV level resulted in a reduction in the patient's effort, such that ventilatory parameters essentially remained unchanged over a wide range of unloading. 11, 12 During the titration procedure, the RRvent decreased minutely from NAVAlow to NAVAal and remained unchanged thereafter. This is in accordance with previous findings in rabbits, 4 healthy subjects, 3 and mechanically ventilated patients, 13 but is clearly different from observations made during pressure support ventilation. 4, 13, 14 The difference in the response of RRvent between NAVA and conventional modes has been attributed to late off-cycling with conventional modes, causing the assist mode of the ventilator to persist into neural exhalation, prolonging exhalation, and reducing RRneural by affecting the Hering-Breuer reflex. 4, 12, 15 Also, increasing the frequency of wasted inspiratory efforts with increasing assist levels has been attributed to the slowing of RRvent during conventional assist. 4, 14, 16 This suggests that RRvent has little value in determining patient comfort and determining the level of unloading in mechanically ventilated patients.
Based on the above discussion, one could hypothesize that the two-phased response in Paw, Ptp, and Vt to the NAVA level titration describes a transition from an initially insufficient level of assist (first response) to an assist level that satisfies the patient's respiratory demand (second response). During the first response, the patient "welcomes" the delivered pressure and allows Paw, Ptp, and Vt to increase, a response that is likely mediated through respiratory muscle afferents. 6, 17 During the second response, the subject's respiratory demand appears to be satisfied, and maintenance of Vt and Ptp by down-regulation of the EAdi becomes prioritized. The second response is likely in part vagally mediated. 10, 18 Although the NAVAhigh for the group was more than twice NAVAal, the increases in mean inspiratory Paw (approximately 1 cm H 2 O) and Vt (approximately 0.8 mL/kg PBW) were relatively small. If the EAdi had not been down-regulated between NAVAal and NAVAhigh, the Paw delivered at NAVAhigh would have been more than double the Paw delivered at NAVAal. The irregular ventilatory pattern at NAVAhigh (Fig 1, B) , which has also been observed in animals 10 and probably reflects overassist, is different from the findings of resonant amplitude oscillations and runaway due to the overcompensation of loads with PAV. 12, 19 With NAVA, the assist is delivered synchronous and proportional to the EAdi even at the highest NAVA levels (ie, at maximal unloading), and regardless of irregularities in the breathing pattern. Of note, an irregular breathing pattern can frequently be observed in mechanically ventilated subjects and per se does not necessarily indicate overassist.
The optimal speed of performing the NAVA level titration procedure has not been established. We opted for a slow increase in the NAVA level (3 min at each NAVA level) to ensure that patients would adapt to each new level. This approach seems to have been effective, as respiratory parameters during the implementation of NAVAal for 3 h were not different from those observed during the titration procedure at NAVAal. Viale et al 20 demonstrated that it takes only five to six breaths for the respiratory drive to adjust after a change in PSV, suggesting that the rate of increase in NAVA levels during a titration could probably be faster, and that, therefore, a NAVA level titration procedure might be also applicable in more severely ill patients.
A reduction in PEEP by about 6 cm H 2 O caused a small but significant increase in mean expiratory EAdi, the so-called tonic EAdi. Although lower in magnitude, this is consistent with the findings by our group of a vagally mediated tonic EAdi in rabbits with acute lung injury 2 and in intubated pediatric patients 21 following a reduction of PEEP. The presence of tonic EAdi and the absence of a decrease in pulse oximetric saturation with reduced PEEP in our patients is in support of a reflex preventing the lungs from derecruitment.
During 3 h receiving NAVAal, all respiratory parameters as well as cardiopulmonary function remained stable, and there was no indication of respiratory failure in any patient. 22, 23 The median Vt of the group was close to 6 mL/kg PBW, a value chosen somewhat arbitrarily by the ARDSNet investigators 24 for their lung-protective strategy. However, in contrast to the ARDSNet study, 24 the variability in Vt among our patients was high, ranging from 4.5 to 10.1 mL/kg PBW. The positive correlation between Vt and CLdyn during NAVAal raises the possibility that choosing the level of assist based on a NAVA level titration may provide an approach to individualizing ventilatory parameters. Our finding that neural feedback promotes lower Vt by down-regulating inspiratory effort in patients with the least compliant lungs agrees with current perceptions about protection against ventilator-induced lung injury. [25] [26] [27] In the present study, the coefficient of variation for Vt during NAVA was more than twice the value during CoVent. Previous work 28, 29 has shown a similar increase in Vt variability with PAV compared to PSV, suggesting that adjusting the ventilator assist in proportion to the patient's demand on a breath-bybreath basis enhances the patient's ability to respond quickly to alterations in both the respiratory demand and the functional properties of the respiratory system.
Conclusion
This study demonstrates in patients with hypoxemic respiratory failure that NAVA (1) is well integrated into and modulated by respiratory system feedback, and (2) substantially reduces respiratory drive and unloads respiratory muscles. Systematically increasing the NAVA level offers a method to determine a level of adequate unloading based on a characteristic response of Paw and Vt. The implementation of the titrated NAVA level (NAVAal) for 3 h results in sustained unloading with protective Vt, while breathing pattern and cardiopulmonary function remain stable, suggesting that NAVA is a feasible mode of ventilation for critically ill patients with hypoxemic respiratory failure. Although the present study provides principal evidence of the physiologic response to increasing the NAVA level, future studies are required to standardize the titration procedure and the identification of NAVAal.
